$5.75 -0.23 (-3.85%)
11/27/2009 1:00 PM

Halozyme Therapeutics, Inc. (HALO)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Featured Broker Partners